Clinical trial
A Phase II Study of Intravenous Azacitidine Alone in Patients With…
NCT00384956 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00384956 |
|---|---|
| Title | A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes |
| Official title | A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Azacitidine |
| Enrollment | 25 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 1, 2010 |
| First posted | Oct 6, 2006 |
| Last update posted | Dec 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: